Further Readings

Anderson, A.C. 2003. The process of structure-based drug design. Chem. Biol. 10:787-797. B0ges0, K.P. 1998. Drug hunting. The medicinal chemistry of 1-piperazino-3-phenylindans and related compounds. DSc Thesis, The Royal Danish School of Pharmacy, Copenhagen. Brauner-Osborne, H., Egebjerg, J., Nielsen, E.0., Madsen, U., and Krogsgaard-Larsen, P. 2000. Ligands for glutamate receptors: Design and therapeutic prospects. J. Med. Chem. 43:2609-2645. Ebert, B., Madsen, U., S0by, K.K., and Krogsgaard-Larsen, P. 1996. Functional partial agonism at ionotropic excitatory amino acid receptors. Neurochem. Int. 29:309-316. Lindsay, M.A. 2003. Target discovery. Nat. Rev. Drug Disc. 2:831-838.

Lipinsky, C.A., Lombardo, F., Dominy, B.W., and Feeney, P.J. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Del. Rev. 46:3-26.

Mitscher, L.A. 2002. Drug design and discovery: An overview. In Textbook of Drug Design and Discovery,

P. Krogsgaard-Larsen, T. Liljefors, and U. Madsen (eds.), pp. 1-34. London: Taylor & Francis. Patani, G.A. and LaVoie, E.J. 1996. Bioisosterism: A rational approach in drug design. Chem. Rev. 96:3147-3176.

Was this article helpful?

0 0

Post a comment